QHSLab, Inc. Files 8-K: Regulation FD & Financials
Ticker: USAQ · Form: 8-K · Filed: Nov 25, 2024 · CIK: 856984
Sentiment: neutral
Topics: regulation-fd, financial-statements, corporate-history
TL;DR
QHSLab filed an 8-K for Reg FD and financials. Formerly USA Equities.
AI Summary
On November 25, 2024, QHSLab, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as USA EQUITIES CORP. and AMERICAN BIOGENETIC SCIENCES INC, is incorporated in Nevada and its fiscal year ends on December 31st. Its principal business address is in West Palm Beach, Florida.
Why It Matters
This 8-K filing provides important updates on QHSLab, Inc.'s regulatory disclosures and financial reporting, which are crucial for investors to assess the company's current status and performance.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial statements and regulatory information, not indicating any immediate operational or financial distress.
Key Players & Entities
- QHSLab, Inc. (company) — Registrant
- USA EQUITIES CORP. (company) — Former Company Name
- AMERICAN BIOGENETIC SCIENCES INC (company) — Former Company Name
- November 25, 2024 (date) — Report Date
FAQ
What is the primary purpose of this 8-K filing for QHSLab, Inc.?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.
When was this 8-K report filed?
This 8-K report was filed on November 25, 2024.
What are some of the former names of QHSLab, Inc. mentioned in the filing?
Some of the former names of QHSLab, Inc. mentioned in the filing include USA EQUITIES CORP. and AMERICAN BIOGENETIC SCIENCES INC.
In which state is QHSLab, Inc. incorporated?
QHSLab, Inc. is incorporated in Nevada.
What is the business address of QHSLab, Inc.?
The business address of QHSLab, Inc. is 901 Northpoint Parkway, Suite 302, West Palm Beach, FL 33407.
Filing Stats: 663 words · 3 min read · ~2 pages · Grade level 10.8 · Accepted 2024-11-25 08:30:20
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value USAQ N/A Item 7.01 Regu
Filing Documents
- form8-k.htm (8-K) — 41KB
- ex99-1.htm (EX-99.1) — 21KB
- ex99-1_001.jpg (GRAPHIC) — 29KB
- 0001493152-24-047553.txt ( ) — 274KB
- usaq-20241125.xsd (EX-101.SCH) — 3KB
- usaq-20241125_lab.xml (EX-101.LAB) — 33KB
- usaq-20241125_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this current report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: November 25, 2024 QHSLab, Inc. /s/ Troy Grogan Name: Troy Grogan Title: CEO and Chairman